isoproterenol has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 10 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the arrhythmic response to isoproterenol and exercise testing in newly diagnosed arrhythmogenic right ventricular cardiomyopathy (ARVC) patients." | 7.88 | Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients. ( Cheniti, G; Cochet, H; Denis, A; Derval, N; Douard, H; Duchateau, J; Frontera, A; Haïssaguerre, M; Hocini, M; Jaïs, P; Kitamura, T; Lim, HS; Martin, C; Martin, R; Massoullie, G; Pambrun, T; Pillois, X; Sacher, F; Takigawa, M; Vlachos, K, 2018) |
| "Isoproterenol testing was performed with continuous infusion of isoproterenol (45 μg/min) for 3 minutes." | 5.40 | Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy. ( Amraoui, S; Bordachar, P; Cochet, H; Daly, M; Denis, A; Derval, N; Haïssaguerre, M; Hocini, M; Jaïs, P; Komatsu, Y; Lim, HS; Pillois, X; Ploux, S; Ramoul, K; Ritter, P; Sacher, F; Shah, AJ; Zemmoura, A, 2014) |
| "To compare the arrhythmic response to isoproterenol and exercise testing in newly diagnosed arrhythmogenic right ventricular cardiomyopathy (ARVC) patients." | 3.88 | Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients. ( Cheniti, G; Cochet, H; Denis, A; Derval, N; Douard, H; Duchateau, J; Frontera, A; Haïssaguerre, M; Hocini, M; Jaïs, P; Kitamura, T; Lim, HS; Martin, C; Martin, R; Massoullie, G; Pambrun, T; Pillois, X; Sacher, F; Takigawa, M; Vlachos, K, 2018) |
| "Isoproterenol testing was performed with continuous infusion of isoproterenol (45 μg/min) for 3 minutes." | 1.40 | Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy. ( Amraoui, S; Bordachar, P; Cochet, H; Daly, M; Denis, A; Derval, N; Haïssaguerre, M; Hocini, M; Jaïs, P; Komatsu, Y; Lim, HS; Pillois, X; Ploux, S; Ramoul, K; Ritter, P; Sacher, F; Shah, AJ; Zemmoura, A, 2014) |
| "We hypothesized that VT in arrhythmogenic right ventricular dysplasia/cardiomyopathy shows a high degree of association with the PVC at baseline." | 1.39 | High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. ( Bhonsale, A; Calkins, H; James, C; Laurita, KR; Madhavan, S; Murray, B; Nazarian, S; Needleman, M; Philips, B; Tandri, H; Tichnell, C, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Opbergen, CJM | 1 |
| Bagwan, N | 1 |
| Maurya, SR | 1 |
| Kim, JC | 1 |
| Smith, AN | 1 |
| Blackwell, DJ | 1 |
| Johnston, JN | 1 |
| Knollmann, BC | 1 |
| Cerrone, M | 1 |
| Lundby, A | 1 |
| Delmar, M | 1 |
| Denis, A | 4 |
| Sacher, F | 4 |
| Derval, N | 4 |
| Martin, R | 2 |
| Lim, HS | 2 |
| Pambrun, T | 2 |
| Massoullie, G | 1 |
| Duchateau, J | 1 |
| Cochet, H | 3 |
| Pillois, X | 3 |
| Cheniti, G | 1 |
| Frontera, A | 2 |
| Takigawa, M | 1 |
| Vlachos, K | 1 |
| Martin, C | 1 |
| Kitamura, T | 1 |
| Hocini, M | 3 |
| Douard, H | 1 |
| Jaïs, P | 3 |
| Haïssaguerre, M | 3 |
| El-Battrawy, I | 2 |
| Zhao, Z | 1 |
| Lan, H | 1 |
| Cyganek, L | 1 |
| Tombers, C | 1 |
| Li, X | 1 |
| Buljubasic, F | 1 |
| Lang, S | 2 |
| Tiburcy, M | 1 |
| Zimmermann, WH | 1 |
| Utikal, J | 1 |
| Wieland, T | 1 |
| Borggrefe, M | 2 |
| Zhou, XB | 1 |
| Akin, I | 2 |
| Ozeke, O | 1 |
| Cay, S | 1 |
| Ozcan, F | 1 |
| Topaloglu, S | 1 |
| Aras, D | 1 |
| Zhou, X | 1 |
| Shah, AJ | 1 |
| Daly, M | 1 |
| Ramoul, K | 1 |
| Komatsu, Y | 2 |
| Zemmoura, A | 1 |
| Amraoui, S | 2 |
| Ritter, P | 1 |
| Ploux, S | 1 |
| Bordachar, P | 1 |
| Calkins, H | 2 |
| Tandri, H | 2 |
| Berte, B | 1 |
| Yamashita, S | 1 |
| Mahida, S | 1 |
| Wielandts, JY | 1 |
| Sellal, JM | 1 |
| Al Jefairi, N | 1 |
| Montaudon, M | 1 |
| Laurent, F | 1 |
| Philips, B | 1 |
| Madhavan, S | 1 |
| James, C | 1 |
| Tichnell, C | 1 |
| Murray, B | 1 |
| Needleman, M | 1 |
| Bhonsale, A | 1 |
| Nazarian, S | 1 |
| Laurita, KR | 1 |
10 other studies available for isoproterenol and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Exercise Causes Arrhythmogenic Remodeling of Intracellular Calcium Dynamics in Plakophilin-2-Deficient Hearts.
Topics: Animals; Arrhythmias, Cardiac; Arrhythmogenic Right Ventricular Dysplasia; Calcium; Calcium Signalin | 2022 |
Arrhythmogenic response to isoproterenol testing vs. exercise testing in arrhythmogenic right ventricular cardiomyopathy patients.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Case | 2018 |
Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
Topics: Action Potentials; Adrenergic beta-Agonists; Arrhythmogenic Right Ventricular Dysplasia; Calcium Sig | 2018 |
Is there a role of isoproterenol testing in the electrical or concealed phase of arrhythmogenic right ventricular cardiomyopathy as a cardiologist's nightmare?
Topics: Arrhythmias, Cardiac; Arrhythmogenic Right Ventricular Dysplasia; Cardiologists; Dreams; Humans; Iso | 2018 |
Isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy: another brick in the wall?-Authors' reply.
Topics: Arrhythmias, Cardiac; Arrhythmogenic Right Ventricular Dysplasia; Electrocardiography; Humans; Isopr | 2018 |
The pathophysiology of arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
Topics: Arrhythmias, Cardiac; Arrhythmogenic Right Ventricular Dysplasia; Exercise Test; Humans; Isoproteren | 2018 |
Diagnostic value of isoproterenol testing in arrhythmogenic right ventricular cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Early Diagnosis; Electr | 2014 |
High-dose isoproterenol testing for diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy: is there a role?
Topics: Adrenergic beta-Agonists; Arrhythmogenic Right Ventricular Dysplasia; Female; Heart Rate; Humans; Is | 2014 |
Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Arrhythmogenic Right Ventricular Dysplasia; Electrocardiography; El | 2015 |
High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Arrhythmogenic Right Ventricular Dysplasia; Balti | 2013 |